Paxlovid has been available in China since March through hospitals after it was approved in February. These are retail sales, which are different. Out of the many curious decisions by Chinese policymakers, this is rather innocuous, at least to me.

— Winslow Robertson (@Winslow_R) December 15, 2022

China’s rapid unwinding of Covid restrictions has triggered a wave of stockpiling of antiviral drugs such as U.S. pharma giant Pfizer’s Paxlovid, but access to this drug remains limited due to the low domestic supply. https://t.co/JJjZy4y8tI

— Caixin Global (@caixin) December 15, 2022